Detailed Mechanism Funding and Narrative

Years of mechanism: 2010 2011 2012 2013 2014 2015 2016

Details for Mechanism ID: 9879
Country/Region: Uganda
Year: 2016
Main Partner: Management Sciences for Health
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: USAID
Total Funding: $894,778 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $46,636
Care: TB/HIV (HVTB) $11,153
Care: Pediatric Care and Support (PDCS) $12,732
Laboratory Infrastructure (HLAB) $0
Strategic Information (HVSI) $0
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $196,513
Prevention: HIV Testing and Counseling (HVCT) $243,770
Sexual Prevention: Other Sexual Prevention (HVOP) $275,602
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $12,894
Treatment: Adult Treatment (HTXS) $91,221
Treatment: Pediatric Treatment (PDTX) $4,257
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
GEND_GBV_DSD Age/Sex: 10-14 Female 2017 77
GEND_GBV_DSD Age/Sex: 10-14 Male 2017 14
GEND_GBV_DSD Age/Sex: 15-19 Female 2017 135
GEND_GBV_DSD Age/Sex: 15-19 male 2017 26
GEND_GBV_DSD Age/Sex: 20-24 Female 2017 144
GEND_GBV_DSD Age/Sex: 20-24 Male 2017 26
GEND_GBV_DSD Age/Sex: 25-49 Female 2017 55
GEND_GBV_DSD Age/Sex: 25-49 Male 2017 26
GEND_GBV_DSD Age/Sex: <10 Female 2017 26
GEND_GBV_DSD Age/Sex: <10 Male 2017 14
GEND_GBV_DSD By PEP service provision (related to sexual violence services provided) 2017 50
GEND_GBV_DSD By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 120
GEND_GBV_DSD By type of service: Sexual Violence (Post-Rape Care) 2017 423
GEND_GBV_DSD Number of people receiving post-GBV care 2017 543
GEND_GBV_DSD Sum of Age/Sex Disaggregates 2017 131
GEND_GBV_TA Age/Sex: 10-14 Female 2017 268
GEND_GBV_TA Age/Sex: 10-14 Male 2017 62
GEND_GBV_TA Age/Sex: 15-19 Female 2017 468
GEND_GBV_TA Age/Sex: 15-19 Male 2017 88
GEND_GBV_TA Age/Sex: 20-24 Female 2017 440
GEND_GBV_TA Age/Sex: 20-24 Male 2017 100
GEND_GBV_TA Age/Sex: 25-49 Female 2017 194
GEND_GBV_TA Age/Sex: 25-49 Male 2017 100
GEND_GBV_TA Age/Sex: <10 Female 2017 100
GEND_GBV_TA Age/Sex: <10 Male 2017 62
GEND_GBV_TA By PEP service provision (related to sexual violence services provided) 2017 173
GEND_GBV_TA By type of service: Physical and/or Emotional Violence (Other Post-GBV Care) 2017 420
GEND_GBV_TA By type of service: Sexual Violence (Post-Rape Care) 2017 1,462
GEND_GBV_TA Number of people receiving post-GBV care 2017 1,882
GEND_GBV_TA Sum of Age/Sex Disaggregates 2017 492
HTC_TST_DSD Age/sex: 1-9 2017 964
HTC_TST_DSD Age/sex: 10-14 Female 2017 832
HTC_TST_DSD Age/sex: 10-14 Male 2017 830
HTC_TST_DSD Age/sex: 15-19 Female 2017 3,074
HTC_TST_DSD Age/sex: 15-19 Male 2017 3,547
HTC_TST_DSD Age/sex: 20-24 Female 2017 4,617
HTC_TST_DSD Age/sex: 20-24 Male 2017 5,319
HTC_TST_DSD Age/sex: 25-49 Female 2017 7,077
HTC_TST_DSD Age/sex: 25-49 Male 2017 8,156
HTC_TST_DSD Age/sex: 50+ Female 2017 612
HTC_TST_DSD Age/sex: 50+ Male 2017 708
HTC_TST_DSD Age/sex: <1 2017 296
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 15,380
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 17,730
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 1,461
HTC_TST_DSD Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 1,461
HTC_TST_DSD Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 36,032
HTC_TST_DSD Service Delivery Point (Facility): Index testing 2017 259
HTC_TST_DSD Service Delivery Point (Facility): Inpatient 2017 4,467
HTC_TST_DSD Service Delivery Point (Facility): Other PITC 2017 1,073
HTC_TST_DSD Service Delivery Point (Facility): Outpatient 2017 7,675
HTC_TST_DSD Service Delivery Point (Facility): Pediatric 2017 2,657
HTC_TST_DSD Service Delivery Point (Facility): PMTCT 2017 9,485
HTC_TST_DSD Service Delivery Point (Facility): TB Clinics 2017 143
HTC_TST_DSD Service Delivery Point (Facility): VMMC 2017 10,273
HTC_TST_DSD Sum of Age/Sex disaggregates 2017 34,772
HTC_TST_DSD Sum of Aggregated Age/Sex 15+ 2017 33,110
HTC_TST_DSD Sum of Aggregated Age/Sex <15 2017 2,922
HTC_TST_DSD Sum of Aggregated Age/Sex disaggregates 2017 36,032
HTC_TST_DSD Test Result by Age and Sex: Positive: 10-14 Female 2017 21
HTC_TST_DSD Test Result by Age and Sex: Positive: 10-14 Male 2017 18
HTC_TST_DSD Test Result by Age and Sex: Positive: 15-19 Female 2017 63
HTC_TST_DSD Test Result by Age and Sex: Positive: 15-19 Male 2017 29
HTC_TST_DSD Test Result by Age and Sex: Positive: 20-24 Female 2017 97
HTC_TST_DSD Test Result by Age and Sex: Positive: 20-24 Male 2017 48
HTC_TST_DSD Test Result by Age and Sex: Positive: 25-49 Female 2017 142
HTC_TST_DSD Test Result by Age and Sex: Positive: 25-49 Male 2017 69
HTC_TST_DSD Test Result by Age and Sex: Positive: 50+ Female 2017 14
HTC_TST_DSD Test Result by Age and Sex: Positive: 50+ Male 2017 6
HTC_TST_DSD Test Result by Age: Positive: 1-9 2017 18
HTC_TST_DSD Test Result by Age: Positive: <1 2017 6
HTC_TST_DSD Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 316
HTC_TST_DSD Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 152
HTC_TST_DSD Test Result by Aggregated Age and Sex: Positive <15 Female 2017 32
HTC_TST_DSD Test Result by Aggregated Age and Sex: Positive <15 Male 2017 31
HTC_TST_TA Age/sex: 1-9 2017 4,279
HTC_TST_TA Age/sex: 10-14 Female 2017 3,680
HTC_TST_TA Age/sex: 10-14 Male 2017 3,680
HTC_TST_TA Age/sex: 15-19 Female 2017 12,307
HTC_TST_TA Age/sex: 15-19 Male 2017 9,732
HTC_TST_TA Age/sex: 20-24 Female 2017 18,463
HTC_TST_TA Age/sex: 20-24 Male 2017 14,612
HTC_TST_TA Age/sex: 25-49 Female 2017 28,300
HTC_TST_TA Age/sex: 25-49 Male 2017 22,394
HTC_TST_TA Age/sex: 50+ Female 2017 2,455
HTC_TST_TA Age/sex: 50+ Male 2017 1,934
HTC_TST_TA Age/sex: <1 2017 1,304
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 61,525
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 48,672
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 6,474
HTC_TST_TA Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 6,469
HTC_TST_TA Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 123,140
HTC_TST_TA Service Delivery Point (Facility): Index testing 2017 1,437
HTC_TST_TA Service Delivery Point (Facility): Inpatient 2017 21,871
HTC_TST_TA Service Delivery Point (Facility): Other PITC 2017 5,154
HTC_TST_TA Service Delivery Point (Facility): Outpatient 2017 35,979
HTC_TST_TA Service Delivery Point (Facility): Pediatric 2017 12,093
HTC_TST_TA Service Delivery Point (Facility): PMTCT 2017 32,912
HTC_TST_TA Service Delivery Point (Facility): TB Clinics 2017 689
HTC_TST_TA Service Delivery Point (Facility): VMMC 2017 13,005
HTC_TST_TA Sum of Age/Sex disaggregates 2017 117,557
HTC_TST_TA Sum of Aggregated Age/Sex 15+ 2017 110,197
HTC_TST_TA Sum of Aggregated Age/Sex <15 2017 12,943
HTC_TST_TA Sum of Aggregated Age/Sex disaggregates 2017 123,140
HTC_TST_TA Test Result by Age and Sex: Positive: 10-14 Female 2017 90
HTC_TST_TA Test Result by Age and Sex: Positive: 10-14 Male 2017 84
HTC_TST_TA Test Result by Age and Sex: Positive: 15-19 Female 2017 259
HTC_TST_TA Test Result by Age and Sex: Positive: 15-19 Male 2017 129
HTC_TST_TA Test Result by Age and Sex: Positive: 20-24 Female 2017 391
HTC_TST_TA Test Result by Age and Sex: Positive: 20-24 Male 2017 203
HTC_TST_TA Test Result by Age and Sex: Positive: 25-49 Female 2017 590
HTC_TST_TA Test Result by Age and Sex: Positive: 25-49 Male 2017 302
HTC_TST_TA Test Result by Age and Sex: Positive: 50+ Female 2017 37
HTC_TST_TA Test Result by Age and Sex: Positive: 50+ Male 2017 23
HTC_TST_TA Test Result by Age: Positive: 1-9 2017 81
HTC_TST_TA Test Result by Age: Positive: <1 2017 10
HTC_TST_TA Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,277
HTC_TST_TA Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 657
HTC_TST_TA Test Result by Aggregated Age and Sex: Positive <15 Female 2017 137
HTC_TST_TA Test Result by Aggregated Age and Sex: Positive <15 Male 2017 128
KP_PREV_DSD By key population type: Female sex workers (FSW) (Denominator: Total estimated number of key population in the catchment area) 2017 3,593
KP_PREV_DSD By key population type: Men who have sex with men who are NOT sex workers (Denominator: Total estimated number of key population in the catchment area) 2017 81
KP_PREV_DSD By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 23
KP_PREV_DSD By key population type: Men who have sex with men who are sex workers (Denominator: Total estimated number of key population in the catchment area 2017 184
KP_PREV_DSD By key population type: Men who have sex with men who are sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2017 2,151
KP_PREV_DSD Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2017 2,174
KP_PREV_DSD Total estimated number of key population in the catchment area 2017 3,858
PMTCT_ART_DSD Already on ART at beginning of current pregnancy 2017 186
PMTCT_ART_DSD New on ART 2017 134
PMTCT_ART_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 9,665
PMTCT_ART_TA Already on ART at beginning of current pregnancy 2017 598
PMTCT_ART_TA New on ART 2017 427
PMTCT_ART_TA Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 33,520
PMTCT_EID_DSD By infants who received a virologic test within 2 months of birth 2017 210
PMTCT_EID_DSD By infants who received their first virologic HIV test between 2 and 12 months of age 2017 61
PMTCT_EID_DSD Number of infants with a positive virological test result within 12 months of birth 2017 1
PMTCT_EID_DSD Number of infants with a positive virological test result within 2 months of birth 2017 10
PMTCT_EID_DSD Sum of Infant Age disaggregates 2017 271
PMTCT_EID_TA By infants who received a virologic test within 2 months of birth 2017 681
PMTCT_EID_TA By infants who received their first virologic HIV test between 2 and 12 months of age 2017 176
PMTCT_EID_TA Number of infants with a positive virological test result within 2 months of birth 2017 34
PMTCT_EID_TA Sum of Infant Age disaggregates 2017 857
PMTCT_STAT_DSD By: Known positives at entry 2017 204
PMTCT_STAT_DSD By: Number of new positives identified 2017 133
PMTCT_STAT_DSD Number of new ANC and L&D clients 2017 9,911
PMTCT_STAT_DSD Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 9,665
PMTCT_STAT_DSD Sum of Positives Status disaggregates 2017 337
PMTCT_STAT_TA By: Known positives at entry 2017 642
PMTCT_STAT_TA By: Number of new positives identified 2017 433
PMTCT_STAT_TA Number of new ANC and L&D clients 2017 34,374
PMTCT_STAT_TA Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 33,520
PMTCT_STAT_TA Sum of Positives Status disaggregates 2017 1,075
PP_PREV_DSD Aggregated Age/sex: 15+ Female 2017 412
PP_PREV_DSD Aggregated Age/sex: 15+ Male 2017 413
PP_PREV_DSD Aggregated Age/sex: <15 Female 2017 348
PP_PREV_DSD Aggregated Age/sex: <15 Male 2017 319
PP_PREV_DSD Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2017 1,514
PP_PREV_DSD Total number of people in the target population 2017 4,402
TB_ART_DSD Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 10
TB_ART_DSD Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 27
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 37
TB_ART_DSD The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 37
TB_ART_TA Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 49
TB_ART_TA Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 146
TB_ART_TA Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 1
TB_ART_TA The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 196
TB_ART_TA The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 196
TB_SCREENDX_DSD Screen Result: Screened Positive for TB 2017 129
TB_SCREENDX_DSD Screened for TB by Age/Sex: 15+ Female 2017 3,936
TB_SCREENDX_DSD Screened for TB by Age/Sex: 15+ Male 2017 2,027
TB_SCREENDX_DSD Screened for TB by Age/Sex:<15 Female 2017 207
TB_SCREENDX_DSD Screened for TB by Age/Sex:<15 Male 2017 179
TB_SCREENDX_DSD The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 6,349
TB_SCREENDX_DSD [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 507
TB_SCREENDX_DSD [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 48
TB_SCREENDX_DSD [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 154
TB_SCREENDX_DSD [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 305
TB_SCREENDX_TA Screen Results: Screened Positive for TB 2017 322
TB_SCREENDX_TA Screened for TB by Age/Sex: 15+ Female 2017 9,948
TB_SCREENDX_TA Screened for TB by Age/Sex: 15+ Male 2017 5,122
TB_SCREENDX_TA Screened for TB by Age/Sex: <15 Female 2017 528
TB_SCREENDX_TA Screened for TB by Age/Sex: <15 Male 2017 457
TB_SCREENDX_TA The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 16,055
TB_SCREENDX_TA [Sub-Disagg of Screen Results] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 1,286
TB_SCREENDX_TA [Sub-disagg of Specimen Sent] Diagnostic Test: Other (Not Xpert) 2017 121
TB_SCREENDX_TA [Sub-disagg of Specimen Sent] Diagnostic Test: Smear Only 2017 390
TB_SCREENDX_TA [Sub-disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 775
TB_STAT_DSD Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 41
TB_STAT_DSD Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 2
TB_STAT_DSD Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 79
TB_STAT_DSD Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 2
TB_STAT_DSD Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 124
TB_STAT_DSD Total number of registered new and relapsed TB cases, during the reporting period 2017 124
TB_STAT_TA Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 223
TB_STAT_TA Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 12
TB_STAT_TA Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 406
TB_STAT_TA Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 16
TB_STAT_TA Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 657
TB_STAT_TA Total number of registered new and relapsed TB cases, during the reporting period 2017 657
TX_CURR_DSD Age/Sex: 10-14 Female 2017 151
TX_CURR_DSD Age/Sex: 10-14 Male 2017 126
TX_CURR_DSD Age/Sex: 15-19 Female 2017 197
TX_CURR_DSD Age/Sex: 15-19 Male 2017 61
TX_CURR_DSD Age/Sex: 20-24 Female 2017 904
TX_CURR_DSD Age/Sex: 20-24 Male 2017 407
TX_CURR_DSD Age/Sex: 25-49 Female 2017 2,638
TX_CURR_DSD Age/Sex: 25-49 Male 2017 1,459
TX_CURR_DSD Age/Sex: 50+ Female 2017 197
TX_CURR_DSD Age/Sex: 50+ Male 2017 100
TX_CURR_DSD Age/Sex: <1 2017 15
TX_CURR_DSD Age/Sex: <1-9 2017 94
TX_CURR_DSD Aggregated Age/Sex: 15+ Female 2017 3,936
TX_CURR_DSD Aggregated Age/Sex: 15+ Male 2017 2,027
TX_CURR_DSD Aggregated Age/Sex: <15 Female 2017 207
TX_CURR_DSD Aggregated Age/Sex: <15 Male 2017 179
TX_CURR_DSD Number of adults and children receiving antiretroviral therapy (ART) 2017 6,349
TX_CURR_DSD Sum of age/sex disaggregates 2017 258
TX_CURR_DSD Sum of Aggregated Age/Sex 15+ 2017 5,963
TX_CURR_DSD Sum of Aggregated Age/Sex <15 2017 386
TX_CURR_DSD Sum of Aggregated Age/Sex disaggregates 2017 6,349
TX_CURR_TA Age/Sex: 1-9 2017 254
TX_CURR_TA Age/Sex: 10-14 Female 2017 380
TX_CURR_TA Age/Sex: 10-14 Male 2017 324
TX_CURR_TA Age/Sex: 15-19 Female 2017 496
TX_CURR_TA Age/Sex: 15-19 Male 2017 153
TX_CURR_TA Age/Sex: 20-24 Female 2017 2,287
TX_CURR_TA Age/Sex: 20-24 Male 2017 1,029
TX_CURR_TA Age/Sex: 25-49 Female 2017 6,669
TX_CURR_TA Age/Sex: 25-49 Male 2017 3,684
TX_CURR_TA Age/Sex: 50+ Female 2017 496
TX_CURR_TA Age/Sex: 50+ Male 2017 256
TX_CURR_TA Age/Sex: <1 2017 27
TX_CURR_TA Aggregated Age/Sex: 15+ Female 2017 9,948
TX_CURR_TA Aggregated Age/Sex: 15+ Male 2017 5,122
TX_CURR_TA Aggregated Age/Sex: <15 Female 2017 528
TX_CURR_TA Aggregated Age/Sex: <15 Male 2017 457
TX_CURR_TA Number of adults and children receiving antiretroviral therapy (ART) 2017 16,055
TX_CURR_TA Sum of Age/Sex disaggregations 2017 649
TX_CURR_TA Sum of Aggregated Age/Sex 15+ 2017 15,070
TX_CURR_TA Sum of Aggregated Age/Sex <15 2017 985
TX_CURR_TA Sum of Aggregated Age/Sex disaggregates 2017 16,055
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Female 2017 428
TX_NEW_DSD Aggregated Grouping by Age/Sex: 15+ Male 2017 214
TX_NEW_DSD Aggregated Grouping by Age/Sex: <15 Female 2017 31
TX_NEW_DSD Aggregated Grouping by Age/Sex: <15 Male 2017 23
TX_NEW_DSD By Age/Sex: 1-9 2017 14
TX_NEW_DSD By Age/Sex: 10-14 Female 2017 23
TX_NEW_DSD By Age/Sex: 10-14 Male 2017 16
TX_NEW_DSD By Age/Sex: 15-19 Female 2017 20
TX_NEW_DSD By Age/Sex: 15-19 Male 2017 7
TX_NEW_DSD By Age/Sex: 20-24 Female 2017 101
TX_NEW_DSD By Age/Sex: 20-24 Male 2017 43
TX_NEW_DSD By Age/Sex: 25-49 Female 2017 288
TX_NEW_DSD By Age/Sex: 25-49 Male 2017 154
TX_NEW_DSD By Age/Sex: 50+ Female 2017 19
TX_NEW_DSD By Age/Sex: 50+ Male 2017 10
TX_NEW_DSD By Age/Sex: <1 2017 1
TX_NEW_DSD Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 698
TX_NEW_DSD Sum of Age/Sex disaggregates 2017 681
TX_NEW_DSD Sum of Aggregated Age/Sex disaggregates 2017 696
TX_NEW_TA Aggregated Grouping by Age/Sex: 15+ Female 2017 1,539
TX_NEW_TA Aggregated Grouping by Age/Sex: 15+ Male 2017 780
TX_NEW_TA Aggregated Grouping by Age/Sex: <15 Female 2017 145
TX_NEW_TA Aggregated Grouping by Age/Sex: <15 Male 2017 107
TX_NEW_TA Aggregated Grouping by Age: <1 2017 2
TX_NEW_TA By Age/Sex: 1-9 2017 54
TX_NEW_TA By Age/Sex: 10-14 Female 2017 121
TX_NEW_TA By Age/Sex: 10-14 Male 2017 75
TX_NEW_TA By Age/Sex: 15-19 Female 2017 73
TX_NEW_TA By Age/Sex: 15-19 Male 2017 16
TX_NEW_TA By Age/Sex: 20-24 Female 2017 355
TX_NEW_TA By Age/Sex: 20-24 Male 2017 159
TX_NEW_TA By Age/Sex: 25-49 Female 2017 1,029
TX_NEW_TA By Age/Sex: 25-49 Male 2017 563
TX_NEW_TA By Age/Sex: 50+ Female 2017 82
TX_NEW_TA By Age/Sex: 50+ Male 2017 42
TX_NEW_TA Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 2,571
TX_NEW_TA Sum of Age/Sex disaggregates 2017 2,515
TX_NEW_TA Sum of Aggregated Age/Sex disaggregates 2017 2,571
VMMC_CIRC_DSD By Age: 10-14 2017 9,078
VMMC_CIRC_DSD By Age: 15-19 2017 6,750
VMMC_CIRC_DSD By Age: 20-24 2017 3,260
VMMC_CIRC_DSD By Age: 25-29 2017 1,861
VMMC_CIRC_DSD By Age: 30-49 2017 1,861
VMMC_CIRC_DSD By Age: 50+ 2017 468
VMMC_CIRC_DSD By circumcision technique: Surgical VMMC 2017 23,278
VMMC_CIRC_DSD Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2017 23,278
VMMC_CIRC_DSD Sum of age disaggregates (FY15-Current) 2017 23,278
VMMC_CIRC_DSD Sum of age disaggregates (Prior to FY15) 2017 19,556
Cross Cutting Budget Categories and Known Amounts Total: $553,336
Gender: Gender Based Violence (GBV) $376,668
GBV Prevention
Collection and Use of Gender-related Strategic Information
Implementation
Capacity building
Monitoring and Evaluation
Key Populations: MSM and TG $88,334
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Training of health workers and community outreach workers
Key Populations: FSW $88,334
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Collection and use of strategic information on SWs and clients
Training of health workers and community outreach workers